Rioja P, Ruiz R, Galvez-Nino M, Lozano S, Valdiviezo N, Olivera M, Cabero O, Guillen ME, De La Guerra A, Amorin E, Barrionuevo C, Mas L. Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution. Thorac Cancer. 2021;12(4):420–5. Epub 2020 Dec 23. PMID: 33356008; PMCID: PMC7882391.

Article  CAS  PubMed  Google Scholar 

Zhao J, Bhatnagar V, Ding L, Atay SM, David EA, McFadden PM, Stamnes S, Lechtholz-Zey E, Wightman SC, Detterbeck FC, Kim AW. A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020;160(1):306–e31414. Epub 2019 Dec 2. PMID: 31982129.

Article  PubMed  Google Scholar 

Malfitano AM, D’Esposito V, De Placido P, Tortora M, Ottaviano M, Pietroluongo E, Morra R, Mucci B, Napolitano F, Montella L, Giuliano M, De Placido S, Terracciano D, Palmieri G, Formisano P. Immunological signature of patients with thymic epithelial tumors and good syndrome. Front Immunol. 2022;13:908453. https://doi.org/10.3389/fimmu.2022.908453.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelleher P, Misbah SA. What is Good’s syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol. 2003;56(1):12–6. https://doi.org/10.1136/jcp.56.1.12. PMID: 12499426; PMCID: PMC1769851.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masci AM, Palmieri G, Vitiello L, Montella L, Perna F, Orlandi P, Abbate G, Zappacosta S, De Palma R, Racioppi L. Clonal expansion of CD8 + BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia. Blood. 2003;101(8):3106–8. https://doi.org/10.1182/blood-2002-08-2638. Epub 2002 Dec 19. PMID: 12515721.

Article  CAS  PubMed  Google Scholar 

Paganelli R, Di Lizia M, D’Urbano M, Gatta A, Paganelli A, Amerio P, Parronchi P. Insights from a case of Good’s syndrome (immunodeficiency with Thymoma). Biomedicines. 2023;11(6):1605. https://doi.org/10.3390/biomedicines11061605. PMID: 37371700; PMCID: PMC10296089.

Article  PubMed  PubMed Central  Google Scholar 

Hayward AR, Paolucci P, Webster AD, Kohler P. Pre-B cell suppression by thymoma patient lymphocytes. Clin Exp Immunol. 1982;48(2):437–42. PMID: 6980746; PMCID: PMC1536454.

CAS  PubMed  PubMed Central  Google Scholar 

Zaman M, Huissoon A, Buckland M, Patel S, Alachkar H, Edgar JD, Thomas M, Arumugakani G, Baxendale H, Burns S, Williams AP, Jolles S, Herriot R, Sargur RB, Arkwright PD. Clinical and laboratory features of seventy-eight UK patients with Good’s syndrome (thymoma and hypogammaglobulinaemia). Clin Exp Immunol. 2019;195(1):132–8. https://doi.org/10.1111/cei.13216. Epub 2018 Oct 21. PMID: 30216434; PMCID: PMC6300645.

Article  CAS  PubMed  Google Scholar 

Sun X, Shi J, Wang M, Xu K, Xiao Y. Good’s syndrome patients hospitalized for infections: a single-Center Retrospective Study. Med (Baltim). 2015;94(47):e2090. https://doi.org/10.1097/MD.0000000000002090. PMID: 26632723; PMCID: PMC5058992.

Article  Google Scholar 

Pietroluongo E, De Placido P, Picozzi F, Morra R, Tortora M, Del Deo V, Montella L, Palmieri G, Buonomo AR, De Placido S, Gentile I, Giuliano M. Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic. Mediastinum (Hong Kong China). 2022;7:8. https://doi.org/10.21037/med-21-47.

Article  PubMed  Google Scholar 

Aiom. Raccomandazioni 2020 su tumori epiteliali del timo (TET). Italian Association of Medical Oncology (AIOM) Thymic epithelial tumors (TET) recommendations 2020. https://www.aiom.it/raccomandazioni-2020-su-tumori-epiteliali-del-timo-tet/. Accessed December 13, 2022.

https://www.covid19treatmentguidelines.nih.gov/.

https://www.aifa.gov.it/vaccini-covid-19.

https://www.aifa.gov.it/uso-degli-anticorpi-monoclonali.

https://www.aifa.gov.it/uso-degli-antivirali-orali-per-covid-19.

Arpino G, et al. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era. ESMO open vol. 2020;5:e000885. https://doi.org/10.1136/esmoopen-2020-000885.

Article  Google Scholar 

Shi Y, Wang C. When the Good Syndrome Goes Bad: A Systematic Literature Review. Frontiers in immunology vol. 12 679556. 25 May. 2021, https://doi.org/10.3389/fimmu.2021.679556.

De Placido P, Pietroluongo E, De Angelis C, Tafuro M, Barraco C, Giannatiempo R, Buonaiuto R, Schettini F, Iervolino A, Vozzella EA, Giuliano M, Bianco R, Arpino G. Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: results of a prospective observational study. Front Oncol. 2022;12:951026. https://doi.org/10.3389/fonc.2022.951026.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pietroluongo E, De Placido P, Tortora M, Martinelli C, Viggiano A, Saponaro MR, Caltavituro A, Buonaiuto R, Morra R, Ottaviano M, Del Deo V, Cernera G, Gelzo M, Malfitano AM, Di Tolla MF, De Angelis C, Arpino G, Terracciano D ... Giuliano M. Impaired seroconversion after severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with thymic epithelial tumors. J Thorac Oncol 2023;18(10):1399–407. https://doi.org/10.1016/j.jtho.2023.06.015.

Cernera G, Gelzo M, De Placido P, Ottaviano M, Pietroluongo E, Raia M, Scalia G, Tortora M, Castaldo G, Formisano P, Palmieri G, Giuliano M. Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response. Front Immunol. 2023;14:1233056. https://doi.org/10.3389/fimmu.2023.1233056.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayoub HH, Mumtaz GR, Seedat S, Makhoul M, Chemaitelly H, Abu-Raddad LJ. Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020. Glob Epidemiol. 2021;3:100068. https://doi.org/10.1016/j.gloepi.2021.100068. Epub 2021 Nov 23. PMID: 34841244; PMCID: PMC8609676.

Article  PubMed  PubMed Central  Google Scholar 

Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis. 2021;72(2):340–50. https://doi.org/10.1093/cid/ciaa863. PMID: 33501974; PMCID: PMC7337668.

Article  CAS  PubMed  Google Scholar 

Seth G, Sethi S, Bhattarai S, Saini G, Singh CB, Aneja R. SARS-CoV-2 infection in Cancer patients: effects on Disease outcomes and Patient Prognosis. Cancers (Basel). 2020;12(11):3266. https://doi.org/10.3390/cancers12113266. PMID: 33167313; PMCID: PMC7694326.

Article  CAS  PubMed  Google Scholar 

Milito C, Firinu D, Bez P, Villa A, Punziano A, Lagnese G, Costanzo G, van Leeuwen LPM, Piazza B, Deiana CM, d’Ippolito G, Del Giacco SR, Rattazzi M, Spadaro G, Quinti I, Scarpa R, Dalm VASH, Cinetto F. A beacon in the dark: COVID-19 course in CVID patients from two European countries: different approaches, similar outcomes. Front Immunol. 2023 Feb.

Drzymalla E, Green RF, Knuth M, Khoury MJ, Dotson WD, Gundlapalli A. COVID-19-related health outcomes in people with primary immunodeficiency: a systematic review. Clin Immunol. 2022;243:109097. https://doi.org/10.1016/j.clim.2022.109097. Epub 2022 Aug 13. PMID: 35973637; PMCID: PMC9375253.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Whisenant, J. G., Baena, J., Cortellini, A., Huang, L. C., Lo Russo, G., Porcu, L.,Wong, S. K., Bestvina, C. M., Hellmann, M. D., Roca, E., Rizvi, H., Monnet, I., Boudjemaa,A., Rogado, J., Pasello, G., Leighl, N. B., Arrieta, O., Aujayeb, A., Batra, U., Azzam,A. Y., … TERAVOLT study group (2022). A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 17(5), 661–674. https://doi.org/10.1016/j.jtho.2021.12.015.